Keywords: modex, forges, ahead, novel, business, strategy, cell-based

Modex forges ahead with novel business strategy in cell-based therapies

Article | 02 November 2000

Switzerland's Modex Therapeutics has a novel approach to thebiotechnology industry in that it does not undertake discovery programs, but in-licenses ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in